Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

BeyondSpring Inc. Ordinary Shares (BYSI)

https://www.beyondspringpharma.com

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/09/2017

Market Cap

77,376,768

Shares Outstanding

38,920,000

Weighted SO

38,924,087

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

SRZN --.--%

ARMP --.--%

KTTA --.--%

ONCT --.--%

ADTX --.--%

SCPH --.--%

MIST --.--%

ONCY --.--%

MCRB --.--%

Beta

0.2530

Last Div

0.0000

Range

0.653-4.0

Chg

0.1500

Avg Vol

48903

Mkt Cap

77376768

Exch

NASDAQ

Country

US

Phone

646 305 6387

DCF Diff

6.2597

DCF

-3.1247

Div Yield

0.0000

P/S

44.1900

EV Multiple

-3.2173

P/FV

-2.7947

Div Yield %

0.0000

P/E

-3.5628

PEG

-0.1100

Payout

0.0000

Current Ratio

2.3145

Quick Ratio

2.3145

Cash Ratio

0.9813

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

1.0000

Op Margin

-13.2005

Pretax Margin

-12.4740

Net Margin

-12.0080

Eff Tax Rate

-0.0057

ROA

-0.8475

ROE

0.9367

ROCE

-1.3718

NI/EBT

0.9626

EBT/EBIT

0.9450

EBIT/Rev

-13.2005

Debt Ratio

0.1610

D/E

-0.1490

LT Debt/Cap

-0.1435

Total Debt/Cap

-0.1751

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

-0.9255

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.2906

Asset Turnover

0.0706

OCF/Share

0.0000

FCF/Share

0.0000

Cash/Share

0.2051

OCF/Sales

0.0000

FCF/OCF

0.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-2.7947

P/B

-2.7947

P/S

44.1900

P/E

-3.5628

P/FCF

0.0000

P/OCF

0.0000

P/CF

0.0000

PEG

-0.1100

P/S

44.1900

EV Multiple

-3.2173

P/FV

-2.7947

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 10, 15:00 BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K GlobeNewswire Inc. Dec 18, 16:30 BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements GlobeNewswire Inc. Oct 26, 08:30 SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium

Revenue Product Segmentation